Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Hoffman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Experimental Neurology|September 19, 1997
In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNFA F Hoffman, C G van Horne, S Eken, et al.
The Journal of Comparative Neurology|May 15, 1995
Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsK E Bowenkamp, A F Hoffman, G A Gerhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophilsP R Farina, A G Graham, A F Hoffman, et al.
Agents and Actions. Supplements|January 1, 1995
Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270T P Parks, A F Hoffman, C A Homon, et al.
Cell Reports|April 23, 2026
Midbrain endocannabinoids actuate dopamine-based action selectionM Á Luján, R Young-Morrison, V Kashtelyan, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Experimental Neurology|September 19, 1997
In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNFA F Hoffman, C G van Horne, S Eken, et al.
The Journal of Comparative Neurology|May 15, 1995
Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsK E Bowenkamp, A F Hoffman, G A Gerhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophilsP R Farina, A G Graham, A F Hoffman, et al.
Agents and Actions. Supplements|January 1, 1995
Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270T P Parks, A F Hoffman, C A Homon, et al.
Cell Reports|April 23, 2026
Midbrain endocannabinoids actuate dopamine-based action selectionM Á Luján, R Young-Morrison, V Kashtelyan, et al.
Pageof 3